Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Completion of share buy-back programme

5 Jun 2024 07:00

RNS Number : 1144R
Seed Innovations Limited
05 June 2024
 

 

5 June 2024

SEED Innovations Limited

("SEED" or the "Company")

 

Completion of Share Buy-Back Programme

 

Payment of maiden dividend of circa. £2 million and £0.51 million Buy-Back programme

 

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to announce completion of its Share Buy-Back Programme (the "Programme") announced via RNS on 19 September 2023 and extended on 29 February 2024. Since the commencement of the Programme, the Company has repurchased 19,797,500 shares for a total consideration of approximately £0.51 million, at an average price of 2.58p per share. This represented 9.31% of the issued share capital of the Company (excluding 2,472,446 treasury shares) when the Programme commenced.

 

Of the issued share capital of 215,219,841 ordinary shares, the Company now holds a total of 22,269,946 shares in treasury, with the remaining 192,949,895 shares representing the total voting rights in the Company which may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

The Programme has been conducted within the safe harbour parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019). Details of all purchases made pursuant to the Programme were announced via RNS and published on the Company's website as required by the Market Abuse Regulations.

 

Commenting on the Programme, SEED CEO Ed McDermott said: "The decision to buy-back some of our shares was made in light of the disparity between the Net Asset Value (NAV) and the share price. The result of the share Buy-Back is over £0.5 million worth of shares bought back and another £2 million returned to Shareholders by way of the 1p special dividend, utilising over £2.5 million in total. It is now time to focus on our existing portfolio and further adding new investments. We believe these will deliver the returns which will allow us to reduce further the shares in issue and deliver further dividends in the future."

 

-Ends-

 

 

For further information on the Company please visit: www.seedinnovations.co or contact: 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro/ Isabel de Salis /Isabelle Morris

 

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

 

Notes

Seed Innovations Ltd

SEED Innovations Ltd is an AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the company is agile and poised to capitalise swiftly on new investment opportunities. 

 

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPUMPQUPCGQC
Date   Source Headline
15th Nov 20231:47 pmRNSTransaction in Own Shares & TVR
15th Nov 20237:00 amRNSTransaction in Own Shares & TVR
14th Nov 20237:00 amRNSTransaction in Own Shares & TVR
13th Nov 20231:01 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Nov 20237:00 amRNSTransaction in Own Shares & TVR
3rd Nov 20237:05 amRNSTransaction in Own Shares & TVR
2nd Nov 20231:16 pmRNSTransaction in Own Shares & TVR
2nd Nov 202311:42 amRNSHolding(s) in Company
31st Oct 202311:27 amRNSInvestee Company Update: Little Green Pharma Ltd
30th Oct 20237:00 amRNSIn-person Shareholder Event in London
27th Oct 20237:00 amRNSTransaction in Own Shares & TVR
24th Oct 202312:30 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSTransaction in Own Shares & TVR
23rd Oct 20237:00 amRNSTransaction in Own Shares & TVR
20th Oct 20237:00 amRNSTransaction in Own Shares & TVR
19th Oct 20237:00 amRNSTransaction in Own Shares & TVR
18th Oct 20237:00 amRNSTransaction in Own Shares & TVR
17th Oct 20237:00 amRNSTransaction in Own Shares & TVR
16th Oct 20237:00 amRNSTransaction in Own Shares & TVR
13th Oct 202312:01 pmRNSTransaction in Own Shares & TVR
12th Oct 20237:00 amRNSTransaction in Own Shares & TVR
11th Oct 20237:00 amRNSTransaction in Own Shares & TVR
10th Oct 202311:37 amRNSTransaction in Own Shares & TVR
9th Oct 20237:00 amRNSTransaction in Own Shares & TVR
6th Oct 20238:06 amRNSTransaction in Own Shares & TVR
5th Oct 20235:23 pmRNSTransaction in Own Shares & TVR
4th Oct 20237:00 amRNSTransaction in Own Shares & TVR
3rd Oct 20233:40 pmRNSTransaction in Own Shares & TVR
20th Sep 202311:00 amRNSResult of AGM
19th Sep 20236:00 pmRNSShare Buy-Back Programme
13th Sep 20235:34 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSPartial Sale of Avextra:60% Premium to Entry Point
8th Sep 202312:15 pmRNSInvestee Company Updates: Northern Leaf & OTO
7th Sep 202310:40 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Sep 20237:01 amRNSNotice of AGM & Investor Presentation
1st Sep 20237:00 amRNSAppointment of Executive Director
16th Aug 202311:00 amRNSInvestee Company Update: Little Green Pharma Ltd
14th Aug 20237:15 amRNSInvestee Company Update: Clean Food Group
8th Aug 20237:00 amRNSClean Food Group Update: Strategic Collaboration
3rd Aug 20237:00 amRNSInvestee Company Update: Portage Biotech Inc
3rd Aug 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
28th Jul 20231:46 pmRNSInvestee Company Update: Little Green Pharma Ltd
12th Jul 20231:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Jun 20232:38 pmRNSInvestee Company Update: Little Green Pharma Ltd
27th Jun 20237:00 amRNSFinal Results
12th Jun 20238:07 amRNSPortfolio Company Update: Northern Leaf Limited
1st Jun 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th May 202312:50 pmRNSInvestee Company Update: Avextra
9th May 20231:37 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th May 20239:45 amRNSInvestee Company Update: Little Green Pharma Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.